|
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
1 |
[GO] |
2024―Jun―06 |
Comparison of the Effects of Different COVID-19 Vaccine Platforms on the Hospitalization Rate |
Abolfazl Gilani, Saeedeh Hajebi Khaniki, Fatemeh Khazaei Fard, Ehsan Baradaran Sirjani, Roham Sarmadian |
2 |
[GO] |
2024―Jun―06 |
Yeast-Produced S1 Recombinant Protein of SARS-CoV-2 |
Sanaz Majidi, Khosrow Aghaeipour, Bahmann Abedi Kiasari, Meisam Akrami, Ashraf Mohammadi, Hamideh Najafi, Fatemeh Sadat Mousavi |
3 |
[GO] |
2024―Jun―06 |
Efficacy of Two Vaccine Platforms against SARS-CoV-2 |
Ali ghazavi, Mohsen khaki, Ghasem Mosayebi, Nafiseh Keshavarzian, Parnian Navabi, Ali Ganji |
4 |
[GO] |
2024―Jun―06 |
SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development |
Mahboubeh Zarei, Alireza Zakeri, Saeed Khalili, Zahra Sadat Hashemi |
5 |
[GO] |
2024―Jun―06 |
Which One Should Be Prioritized During Pandemics: Patents or Global Health? |
Say-yed Hesameddin Tafreshi |
6 |
[GO] |
2022―Okt―31 |
Roles and Functions of Toll-Like Receptors in Coronavirus Infections: Forthcoming Vaccine and Therapeutic Strategies for Confronting COVID-19 |
Azadeh Zahmatkesh, Masoumeh Bagheri |
7 |
[GO] |
2022―Okt―31 |
Basic characteristics of patients with COVID-19 after SARS-CoV-2 vaccine: One cross-sectional study in Iran |
Arezoo Chouhdari, Yasamin Khosravani-Nezhad, Termeh Tarjoman, Mehrangiz Zangeneh |
8 |
[GO] |
2022―Okt―31 |
Lessons Learned from Global Administration of Sinopharm (BBIBP-CorV) Vaccine and Its Efficacy against COVID-19 in Older People |
Shyh Poh Teo |
9 |
[GO] |
2022―Okt―31 |
Acceptance of COVID-19 Vaccination at Different Hypothetical Efficacy and Safety Levels in Nigeria: A Cross-Sectional Web-based Survey |
Richard Akele, Seyi Enitan, Esther Adejumo, Eyiuche Ezigbo, Abiodun Durosinmi, Grace Itodo, Adedeji Abdulsalam, Michael Dada, Okeoghene Edafetanure-Ibeh, Oyekan Oyedoyin, Polit Yelpoji, Abah Idoko, Ogunwola Opeyemi, Ogbuji Nmesomachi, Edwin Okafor, Adesola Oyekale |
10 |
[GO] |
2022―Okt―31 |
Commentary on Corneal Graft Rejection after COVID-19 Vaccination: Our Experience and Concerns |
Radhika Natarajan, Swetha Ravichandran |
11 |
[GO] |
2022―Okt―31 |
An Update on Pathogenesis, Diagnosis and Treatment of COVID-19-Related Cytokine Storm |
Mehmet soy, Pamir ATAGUNDUZ, Gokhan Keser |
12 |
[GO] |
2022―Apr―16 |
Assembling the Most Antigenic Peptides of COVID-19 Immunogenic Proteins Along with a Molecular Adjuvant to Develop a Novel Polyepitope Vaccine: a Bioinformatics Investigation |
Nemat Shams, narges nazifi, Ali Forouharmehr, Amin jaydari, Ehsan rashidian |
13 |
[GO] |
2022―Apr―16 |
Two Months Follow-Up of 139 Unvaccinated COVID-19 Patients Based on Clinical and Imaging Data |
Mehrangiz Zangeneh, Yasamin Khosravani-Nezhad, Mohsen Alijani, Behnam Farhoodi, Hamid-Reza Massumi-Naini, Seyed-Davar Siadat, Masoomeh Mesgarian |
14 |
[GO] |
2022―Apr―16 |
Cutaneous Reactions after COVID-19 vaccines |
Alicia Wan Yan Poh, Shyh Poh Teo |
15 |
[GO] |
2022―Apr―16 |
Quantitative Approaches for Causality Assessment of Adverse Events Following Immunisation for COVID-19 Vaccines |
Shyh Poh Teo |
16 |
[GO] |
2022―Apr―16 |
Back to the Basics: The Good Old BCG for COVID-19? |
Nada Boutrid, Hakim Rahmoune, Hala Boutrid |
17 |
[GO] |
2022―Apr―16 |
Pulmonary Thromboembolism Followed by Deep Vein Thrombosis In A Young Man With G6PD Deficiency After ChAd0x1 nCoV-19 Vaccine Administration |
Arda kiani, Atefeh Abedini, Zahra Sadat Rouhani, Mohammadhossein Banitorfi, Amirhossein Saeidi, Hamidreza Zaheri |
18 |
[GO] |
2021―Okt―04 |
Ethical Considerations and Challenges Duringthe COVID-19 Vaccine Deployment: Experiences from an Indian Perspective |
Saurav Basu, Suruchi Mishra |
19 |
[GO] |
2021―Okt―04 |
Patients with COVID-19-Associated Hematologic Abnormalities and the Potential Role of the Cytokine Storm: A Case Series Study |
Ali Asadollahi-Amin, Fereshteh Ghiasvand, Mehrdad Hasibi, Simin Seyedpour, Alireza Barzegary, Fatemeh Ghadimi, SeyedAhmad SeyedAlinaghi, Omid Dadras |
20 |
[GO] |
2020―Okt―05 |
The Potential of Self-amplifying RNA Vaccines for Infectious Diseases and COVID-19 |
Kenneth Lundstrom |
21 |
[GO] |
2020―Jun―28 |
Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges |
Pooneh Rhimi, Mohammad Reza Aghasadeghi |